L3VLUP
ProSign in

MEDP in the 13F filings

Medpace HLDGS Inc · CUSIP 58506Q109

Sector · Health care services and researchTheme · Healthcare: biopharma and medtech· L3VLUP-defined
Quarter
Q3 2026 · early filersQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023
Quarter end
31 Mar 2025
the date the book describes
Filed
15 May 2025
latest of these filings; the earliest 7 May 2025
Managers listing it
12
at least, of 95 tracked, among listed positions
Comparable managers
95
filed both Q4 2024 and Q1 2025; 10 listed it in both
Shares listed
3,256,546
combined, among listed positions
Reported value
$986m
combined, at the quarter end

Among the 95 comparable managers: 11 buyers (opened or added shares) and 1 seller (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.

Managers listing MEDP in Q1 2025

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q4 2024, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

12 of 12 holders

ActionFiling
Invesco Ltd1,186,768$362m0.07%Added+102,01512 May 2025 (the filing on sec.gov)
Renaissance Technologies LLC577,688$176m0.27%Added+24,10014 May 2025 (the filing on sec.gov)
AQR Capital Management LLC539,547$158m0.16%Added+59,36115 May 2025 (the filing on sec.gov)
Two Sigma Advisers LP244,500$74m0.17%Added+32,00015 May 2025 (the filing on sec.gov)
Two Sigma Investments LP234,905$72m0.15%Added+80,40015 May 2025 (the filing on sec.gov)
D. E. Shaw & Co.214,178$65m0.06%Added+35,89815 May 2025 (the filing on sec.gov)
Voloridge Investment Management LLC195,940$60m0.22%Added+31,73215 May 2025 (the filing on sec.gov)
Polen Capital Management LLC24,466$7.5munder 0.1%Added+8,24312 May 2025 (the filing on sec.gov)
Winton Group Ltd19,954$6.1m0.37%Added+16,61115 May 2025 (the filing on sec.gov)
Maverick Capital Ltd10,228$3.1m0.06%Newnew15 May 2025 (the filing on sec.gov)
Baillie Gifford & Co4,302$1.3munder 0.1%Trimmed-10,1847 May 2025 (the filing on sec.gov)
Brevan Howard Capital Management LP4,070$1.2munder 0.1%Newnew15 May 2025 (the filing on sec.gov)

Largest increases and reductions, by shares

Q4 2024 to Q1 2025, among managers that listed it in both quarters or opened it.

Increases

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (2)

Exited (0)

No exit shown by a manager’s own filing.

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
15 in Q3 2024 to 9 in Q2 2026

Tracked managers listing it, at least.

051015202017201820192020202120222023202420252026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
MEDP by quarter
QuarterHoldersReported valueBuyersSellers
Q1 20172$21mn.a.n.a.
Q2 20171$14mn.a.n.a.
Q3 20171$19mn.a.n.a.
Q4 20171$23mn.a.n.a.
Q1 20183$37mn.a.n.a.
Q2 20184$59mn.a.n.a.
Q3 201814$247mn.a.n.a.
Q4 20186$119mn.a.n.a.
Q1 20194$100mn.a.n.a.
Q2 20194$117mn.a.n.a.
Q3 20196$140mn.a.n.a.
Q4 20195$122mn.a.n.a.
Q1 20207$144mn.a.n.a.
Q2 20208$173mn.a.n.a.
Q3 202012$218mn.a.n.a.
Q4 20208$187mn.a.n.a.
Q1 20219$153mn.a.n.a.
Q2 20218$156mn.a.n.a.
Q3 202111$413mn.a.n.a.
Q4 202112$668mn.a.n.a.
Q1 20226$107mn.a.n.a.
Q2 20225$97mn.a.n.a.
Q3 20223$59mn.a.n.a.
Q4 202210$269mn.a.n.a.
Q1 202314$275mn.a.n.a.
Q2 202317$468mn.a.n.a.
Q3 202315$378mn.a.n.a.
Q4 202314$501m87
Q1 202417$1.2bn98
Q2 202418$1.3bn99
Q3 202415$918m96
Q4 202415$1.2bn96
Q1 202512$986m111
Q2 202514$1.2bn123
Q3 202517$1.9bn98
Q4 202514$2.1bn1421
Q1 202612$1.8bn1221
Q2 20269$2.7bn821

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

MEDP and LLY →MEDP and JNJ →MEDP and VRTX →Choose a stock to compare with MEDP →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own MEDP, latest filings →Back to the 13F Explorer →